With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular ...

Semaglutide, a GLP-1 agonist, works by mimicking a natural ... So far, no studies directly compare the effectiveness of ...

Users on TikTok have touted the benefits of taking berberine supplements, claiming benefits for weight loss, heart health and more. Do you need them?

The new blockbuster obesity drugs, made famous by Ozempic, are collectively known as GLP-1 agonists ... took the extract for ...

To compare the cardiac and renal impacts of GLP-1 receptor agonists vs. other oral hypoglycemic agents — specifically dipeptidyl peptidase 4 (DPP4) inhibitors — for patients with systemic ...

New Anglo/U.S. obesity and cardiometabolic specialist Verdiva Bio Ltd. has launched with a massive $411 million series A and a portfolio of GLP-1 and amylin agonists in-licensed from China. The lead ...